High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.

Research output: Contribution to journal › Letter › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{0d290f2381634d0d894f5783a52a9348,

title = "High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.",

author = "Tyson, \{L. B.\} and Clark, \{R. A.\} and Gralla, \{R. J.\}",

year = "1982",

month = dec,

language = "English (US)",

volume = "66",

pages = "2108",

journal = "Cancer Treatment Reports",

issn = "0361-5960",

publisher = "U.S. National Cancer Institute",

number = "12",

}

TY - JOUR

T1 - High-dose metoclopramide

T2 - control of dacarbazine-induced emesis in a preliminary trial.

AU - Tyson, L. B.

AU - Clark, R. A.

AU - Gralla, R. J.

PY - 1982/12

Y1 - 1982/12

UR - https://www.scopus.com/pages/publications/17744402068

UR - https://www.scopus.com/pages/publications/17744402068#tab=citedBy

M3 - Letter

C2 - 7139656

AN - SCOPUS:17744402068

SN - 0361-5960

VL - 66

SP - 2108

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

IS - 12

ER -